CORPORATE DEAL SOURCE
CORPORATE DEAL SOURCE
Critical Transactional Insights for Deal-Makers
CORPORATE DEAL SOURCE
Critical Transactional Insights for Deal-Makers

Bilal Sayyed Bilal Sayyed

Subscribe to Bilal Sayyed's Posts
Bilal Sayyed represents clients before the Federal Trade Commission (FTC) and Department of Justice (DOJ) in significant merger, civil and criminal antitrust matters. In addition to his representation of clients in antitrust and competition matters, Bilal represents clients before the FTC in consumer protection investigations. Read Bilal Sayyed's full bio.

US and EU Requirements for Pre-Merger Notification of an Acquisition of a Minority Shareholding Interest


By and on Oct 21, 2016
Posted In Corporate, Mergers & Acquisitions, Uncategorized

In May, the Federal Trade Commission (FTC) required Hikma Pharmaceuticals PLC to divest its 23 percent interest in Unimark Remedies, Ltd. and its US marketing rights to a generic drug under manufacture by Unimark as a condition to allowing Hikma to complete its acquisition of Roxane Laboratories. The FTC was concerned that Hikma’s continued holding...

Continue Reading



BLOG EDITORS

STAY CONNECTED

TOPICS

ARCHIVES